Blauvelt A, Paul C, van de Kerkhof P, Warren R, Gottlieb A, Langley R, Brock F, Arendt C, Boehnlein M, Lebwohl M, Reich K. Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. J of Skin [Internet]. 2020 Jan. 28 [cited 2024 Jul. 3];4(1):S5. Available from: https://jofskin.org/33014/index.php/skin/article/view/809